Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial

OBJECTIVE: To evaluate the impact of once-weekly exenatide (EQW) on microvascular and cardiovascular (CV) outcomes by baseline renal function in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). RESEARCH DESIGN AND METHODS: Least squares mean difference (LSMD) in estimated glomerular fi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Care
Main Authors: Bethel, M. Angelyn, Mentz, Robert J., Merrill, Peter, Buse, John B., Chan, Juliana C., Goodman, Shaun G., Iqbal, Nayyar, Jakuboniene, Neli, Katona, Brian, Lokhnygina, Yuliya, Lopes, Renato D., Maggioni, Aldo P., Ohman, Peter, Tankova, Tsvetalina, Bakris, George L., Hernandez, Adrian F., Holman, Rury R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2020
Assuntos:
Cardiovascular and Metabolic Risk
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7411285/
https://ncbi.nlm.nih.gov/pubmed/31757838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1065
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados